Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis

Abstract Epigenetic alterations, especially histone methylation, are key factors in cell migration and invasion in cancer metastasis. However, in lung cancer metastasis, the mechanism by which histone methylation regulates metastasis has not been fully elucidated. Here, we found that the histone met...

Full description

Bibliographic Details
Main Authors: Kwangho Kim, Tae Young Ryu, Eunsun Jung, Tae-Su Han, Jinkwon Lee, Seon-Kyu Kim, Yu Na Roh, Moo-Seung Lee, Cho-Rok Jung, Jung Hwa Lim, Ryuji Hamamoto, Hye Won Lee, Keun Hur, Mi-Young Son, Dae-Soo Kim, Hyun-Soo Cho
Format: Article
Language:English
Published: Nature Publishing Group 2023-05-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-023-00987-1
_version_ 1797811944750579712
author Kwangho Kim
Tae Young Ryu
Eunsun Jung
Tae-Su Han
Jinkwon Lee
Seon-Kyu Kim
Yu Na Roh
Moo-Seung Lee
Cho-Rok Jung
Jung Hwa Lim
Ryuji Hamamoto
Hye Won Lee
Keun Hur
Mi-Young Son
Dae-Soo Kim
Hyun-Soo Cho
author_facet Kwangho Kim
Tae Young Ryu
Eunsun Jung
Tae-Su Han
Jinkwon Lee
Seon-Kyu Kim
Yu Na Roh
Moo-Seung Lee
Cho-Rok Jung
Jung Hwa Lim
Ryuji Hamamoto
Hye Won Lee
Keun Hur
Mi-Young Son
Dae-Soo Kim
Hyun-Soo Cho
author_sort Kwangho Kim
collection DOAJ
description Abstract Epigenetic alterations, especially histone methylation, are key factors in cell migration and invasion in cancer metastasis. However, in lung cancer metastasis, the mechanism by which histone methylation regulates metastasis has not been fully elucidated. Here, we found that the histone methyltransferase SMYD2 is overexpressed in lung cancer and that knockdown of SMYD2 could reduce the rates of cell migration and invasion in lung cancer cell lines via direct downregulation of SMAD3 via SMYD2-mediated epigenetic regulation. Furthermore, using an in vitro epithelial-mesenchymal transition (EMT) system with a Transwell system, we generated highly invasive H1299 (In-H1299) cell lines and observed the suppression of metastatic features by SMYD2 knockdown. Finally, two types of in vivo studies revealed that the formation of metastatic tumors by shSMYD2 was significantly suppressed. Thus, we suggest that SMYD2 is a potential metastasis regulator and that the development of SMYD2-specific inhibitors may help to increase the efficacy of lung cancer treatment.
first_indexed 2024-03-13T07:30:14Z
format Article
id doaj.art-27c0d4a625994a9cb996c9922caa7bad
institution Directory Open Access Journal
issn 2092-6413
language English
last_indexed 2024-03-13T07:30:14Z
publishDate 2023-05-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj.art-27c0d4a625994a9cb996c9922caa7bad2023-06-04T11:07:27ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132023-05-0155595296410.1038/s12276-023-00987-1Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasisKwangho Kim0Tae Young Ryu1Eunsun Jung2Tae-Su Han3Jinkwon Lee4Seon-Kyu Kim5Yu Na Roh6Moo-Seung Lee7Cho-Rok Jung8Jung Hwa Lim9Ryuji Hamamoto10Hye Won Lee11Keun Hur12Mi-Young Son13Dae-Soo Kim14Hyun-Soo Cho15Korea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyDivision of Molecular Modification and Cancer Biology, National Cancer CenterDepartment of Pathology, Keimyung University School of MedicineDepartment of Biochemistry and Cell Biology, School of Medicine, Kyungpook National UniversityKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyKorea Research Institute of Bioscience and BiotechnologyAbstract Epigenetic alterations, especially histone methylation, are key factors in cell migration and invasion in cancer metastasis. However, in lung cancer metastasis, the mechanism by which histone methylation regulates metastasis has not been fully elucidated. Here, we found that the histone methyltransferase SMYD2 is overexpressed in lung cancer and that knockdown of SMYD2 could reduce the rates of cell migration and invasion in lung cancer cell lines via direct downregulation of SMAD3 via SMYD2-mediated epigenetic regulation. Furthermore, using an in vitro epithelial-mesenchymal transition (EMT) system with a Transwell system, we generated highly invasive H1299 (In-H1299) cell lines and observed the suppression of metastatic features by SMYD2 knockdown. Finally, two types of in vivo studies revealed that the formation of metastatic tumors by shSMYD2 was significantly suppressed. Thus, we suggest that SMYD2 is a potential metastasis regulator and that the development of SMYD2-specific inhibitors may help to increase the efficacy of lung cancer treatment.https://doi.org/10.1038/s12276-023-00987-1
spellingShingle Kwangho Kim
Tae Young Ryu
Eunsun Jung
Tae-Su Han
Jinkwon Lee
Seon-Kyu Kim
Yu Na Roh
Moo-Seung Lee
Cho-Rok Jung
Jung Hwa Lim
Ryuji Hamamoto
Hye Won Lee
Keun Hur
Mi-Young Son
Dae-Soo Kim
Hyun-Soo Cho
Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
Experimental and Molecular Medicine
title Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
title_full Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
title_fullStr Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
title_full_unstemmed Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
title_short Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
title_sort epigenetic regulation of smad3 by histone methyltransferase smyd2 promotes lung cancer metastasis
url https://doi.org/10.1038/s12276-023-00987-1
work_keys_str_mv AT kwanghokim epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT taeyoungryu epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT eunsunjung epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT taesuhan epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT jinkwonlee epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT seonkyukim epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT yunaroh epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT mooseunglee epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT chorokjung epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT junghwalim epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT ryujihamamoto epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT hyewonlee epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT keunhur epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT miyoungson epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT daesookim epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis
AT hyunsoocho epigeneticregulationofsmad3byhistonemethyltransferasesmyd2promoteslungcancermetastasis